![Assessment of
<i>TP53</i>
Polymorphisms and
<i>MDM2</i>
SNP309 in Premenopausal Breast Cancer Risk]()
Assessment of
<i>TP53</i>
Polymorphisms and
<i>MDM2</i>
SNP309 in Premenopausal Breast Cancer RiskSamuel, Nardin; Id Said, Badr; Guha, Tanya; Novokmet, Ana; Li, Weili; Silwal-Pandit, Laxmi; Børrsen-Dale, Anne-Lise; Langerød, Anita; Hudson, Thomas J.; Malkin, David · Human Mutation · 2017